Literature DB >> 28935639

Isolation and characterization of endothelial-to-mesenchymal transition cells in pulmonary arterial hypertension.

Toshio Suzuki1,2, Erica J Carrier1, Megha H Talati1, Anandharajan Rathinasabapathy1, Xinping Chen1, Rintaro Nishimura2,3, Yuji Tada2, Koichiro Tatsumi2, James West1.   

Abstract

Endothelial-to-mesenchymal transition (EndMT) is a process in which endothelial cells lose polarity and cell-to cell contacts, and undergo a dramatic remodeling of the cytoskeleton. It has been implicated in initiation and progression of pulmonary arterial hypertension (PAH). However, the characteristics of cells which have undergone EndMT cells in vivo have not been reported and so remain unclear. To study this, sugen5416 and hypoxia (SuHx)-induced PAH was established in Cdh5-Cre/Gt(ROSA)26Sortm4(ACTB-tdTomato,EGFP)Luo/J double transgenic mice, in which GFP was stably expressed in pan-endothelial cells. After 3 wk of SuHx, flow cytometry and immunohistochemistry demonstrated CD144-negative and GFP-positive cells (complete EndMT cells) possessed higher proliferative and migratory activity compared with other mesenchymal cells. While CD144-positive and α-smooth muscle actin (α-SMA)-positive cells (partial EndMT cells) continued to express endothelial progenitor cell markers, complete EndMT cells were Sca-1-rich mesenchymal cells with high proliferative and migratory ability. When transferred in fibronectin-coated chamber slides containing smooth muscle media, α-SMA robustly expressed in these cells compared with cEndMT cells that were grown in maintenance media. Demonstrating additional paracrine effects, conditioned medium from isolated complete EndMT cells induced enhanced mesenchymal proliferation and migration and increased angiogenesis compared with conditioned medium from resident mesenchymal cells. Overall, these findings show that EndMT cells could contribute to the pathogenesis of PAH both directly, by transformation into smooth muscle-like cells with higher proliferative and migratory potency, and indirectly, through paracrine effects on vascular intimal and medial proliferation.

Entities:  

Keywords:  cell transformation; endothelial-to-mesenchymal transition; paracrine effects; pulmonary arterial hypertension; vascular remodeling

Mesh:

Substances:

Year:  2017        PMID: 28935639      PMCID: PMC5866427          DOI: 10.1152/ajplung.00296.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  38 in total

1.  Endothelial fate mapping in mice with pulmonary hypertension.

Authors:  Lina Qiao; Toshihiko Nishimura; Lingfang Shi; Dane Sessions; Ama Thrasher; James R Trudell; Gerald J Berry; Ronald G Pearl; Peter N Kao
Journal:  Circulation       Date:  2013-11-07       Impact factor: 29.690

2.  Vascular endothelial-cadherin downregulation as a feature of endothelial transdifferentiation in monocrotaline-induced pulmonary hypertension.

Authors:  Ioanna Nikitopoulou; Stylianos E Orfanos; Anastasia Kotanidou; Violetta Maltabe; Nikolaos Manitsopoulos; Panagiotis Karras; Panos Kouklis; Apostolos Armaganidis; Nikolaos A Maniatis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-27       Impact factor: 5.464

3.  BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.

Authors:  Maria-Rosa Ghigna; Christophe Guignabert; David Montani; Barbara Girerd; Xavier Jaïs; Laurent Savale; Philippe Hervé; Vincent Thomas de Montpréville; Olaf Mercier; Olivier Sitbon; Florent Soubrier; Elie Fadel; Gérald Simonneau; Marc Humbert; Peter Dorfmüller
Journal:  Eur Respir J       Date:  2016-11-03       Impact factor: 16.671

4.  Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.

Authors:  Naozumi Hashimoto; Sem H Phan; Kazuyoshi Imaizumi; Masaki Matsuo; Harunori Nakashima; Tsutomu Kawabe; Kaoru Shimokata; Yoshinori Hasegawa
Journal:  Am J Respir Cell Mol Biol       Date:  2009-09-18       Impact factor: 6.914

5.  Isolation of an adult mouse lung mesenchymal progenitor cell population.

Authors:  Ross Summer; Kathleen Fitzsimmons; Daniel Dwyer; Jaime Murphy; Alan Fine
Journal:  Am J Respir Cell Mol Biol       Date:  2007-03-29       Impact factor: 6.914

6.  Endothelial-to-mesenchymal transition contributes to cardiac fibrosis.

Authors:  Elisabeth M Zeisberg; Oleg Tarnavski; Michael Zeisberg; Adam L Dorfman; Julie R McMullen; Erika Gustafsson; Anil Chandraker; Xueli Yuan; William T Pu; Anita B Roberts; Eric G Neilson; Mohamed H Sayegh; Seigo Izumo; Raghu Kalluri
Journal:  Nat Med       Date:  2007-07-29       Impact factor: 53.440

7.  Prolyl-4 Hydroxylase 2 (PHD2) Deficiency in Endothelial Cells and Hematopoietic Cells Induces Obliterative Vascular Remodeling and Severe Pulmonary Arterial Hypertension in Mice and Humans Through Hypoxia-Inducible Factor-2α.

Authors:  Zhiyu Dai; Ming Li; John Wharton; Maggie M Zhu; You-Yang Zhao
Journal:  Circulation       Date:  2016-04-25       Impact factor: 29.690

8.  Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.

Authors:  Lu Long; Mark L Ormiston; Xudong Yang; Mark Southwood; Stefan Gräf; Rajiv D Machado; Matthias Mueller; Bernd Kinzel; Lai Ming Yung; Janine M Wilkinson; Stephen D Moore; Kylie M Drake; Micheala A Aldred; Paul B Yu; Paul D Upton; Nicholas W Morrell
Journal:  Nat Med       Date:  2015-06-15       Impact factor: 53.440

Review 9.  Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.

Authors:  Jane A Leopold; Bradley A Maron
Journal:  Int J Mol Sci       Date:  2016-05-18       Impact factor: 5.923

10.  BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis.

Authors:  Jonathan D W Evans; Barbara Girerd; David Montani; Xiao-Jian Wang; Nazzareno Galiè; Eric D Austin; Greg Elliott; Koichiro Asano; Ekkehard Grünig; Yi Yan; Zhi-Cheng Jing; Alessandra Manes; Massimiliano Palazzini; Lisa A Wheeler; Ikue Nakayama; Toru Satoh; Christina Eichstaedt; Katrin Hinderhofer; Matthias Wolf; Erika B Rosenzweig; Wendy K Chung; Florent Soubrier; Gérald Simonneau; Olivier Sitbon; Stefan Gräf; Stephen Kaptoge; Emanuele Di Angelantonio; Marc Humbert; Nicholas W Morrell
Journal:  Lancet Respir Med       Date:  2016-01-19       Impact factor: 30.700

View more
  40 in total

1.  CrossTalk opposing view: The mouse SuHx model is not a good model of pulmonary arterial hypertension.

Authors:  Sally H Vitali
Journal:  J Physiol       Date:  2018-11-29       Impact factor: 5.182

Review 2.  Endothelial-to-Mesenchymal Transition.

Authors:  Joyce Bischoff
Journal:  Circ Res       Date:  2019-04-12       Impact factor: 17.367

3.  Endothelial-to-Mesenchymal Transition and Inflammation Play Key Roles in Cyclophilin A-Induced Pulmonary Arterial Hypertension.

Authors:  Chao Xue; Sharon Senchanthisai; Mark Sowden; Jinjiang Pang; Jim White; Bradford C Berk
Journal:  Hypertension       Date:  2020-08-24       Impact factor: 10.190

Review 4.  A pro-con debate: current controversies in PAH pathogenesis at the American Thoracic Society International Conference in 2017.

Authors:  Wolfgang M Kuebler; Mark R Nicolls; Andrea Olschewski; Kohtaro Abe; Marlene Rabinovitch; Duncan Stewart; Stephen Y Chan; Nicholas W Morrell; Stephen L Archer; Edda Spiekerkoetter
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-06-07       Impact factor: 5.464

Review 5.  Endothelial to Mesenchymal Transition in Cardiovascular Disease: JACC State-of-the-Art Review.

Authors:  Jason C Kovacic; Stefanie Dimmeler; Richard P Harvey; Toren Finkel; Elena Aikawa; Guido Krenning; Andrew H Baker
Journal:  J Am Coll Cardiol       Date:  2019-01-22       Impact factor: 24.094

6.  Transplantation of Mesenchymal Stem Cells Attenuates Pulmonary Hypertension by Normalizing the Endothelial-to-Mesenchymal Transition.

Authors:  Junyi Huang; Wenju Lu; Haiping Ouyang; Yuqin Chen; Chenting Zhang; Xiaoyun Luo; Meichan Li; Jiaze Shu; Qiuyu Zheng; Haixia Chen; Jiyuan Chen; Haiyang Tang; Dejun Sun; Jason X-J Yuan; Kai Yang; Jian Wang
Journal:  Am J Respir Cell Mol Biol       Date:  2020-01       Impact factor: 6.914

7.  Reactive oxygen species induced Ca2+ influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.

Authors:  Karthik Suresh; Laura Servinsky; Haiyang Jiang; Zahna Bigham; Xin Yun; Corrine Kliment; John Huetsch; Mahendra Damarla; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-01       Impact factor: 5.464

Review 8.  Mitochondrial metabolism in pulmonary hypertension: beyond mountains there are mountains.

Authors:  Miranda K Culley; Stephen Y Chan
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

9.  Direct Extracellular NAMPT Involvement in Pulmonary Hypertension and Vascular Remodeling. Transcriptional Regulation by SOX and HIF-2α.

Authors:  Xiaoguang Sun; Belinda L Sun; Aleksandra Babicheva; Rebecca Vanderpool; Radu C Oita; Nancy Casanova; Haiyang Tang; Akash Gupta; Heather Lynn; Geetanjali Gupta; Franz Rischard; Saad Sammani; Carrie L Kempf; Liliana Moreno-Vinasco; Mohamed Ahmed; Sara M Camp; Jian Wang; Ankit A Desai; Jason X-J Yuan; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2020-07       Impact factor: 6.914

10.  Endothelial to mesenchymal transition during neonatal hyperoxia-induced pulmonary hypertension.

Authors:  Jiannan Gong; Zihang Feng; Abigail L Peterson; Jennifer F Carr; Alexander Vang; Julie Braza; Gaurav Choudhary; Phyllis A Dennery; Hongwei Yao
Journal:  J Pathol       Date:  2020-10-06       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.